Novel progranulin variants do not disrupt progranulin secretion and cleavage

Celeste M. Karch, Amanda T. Jeng, Tara Skorupa, Carlos Cruchaga, Alison M. Goate

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

A subset of frontotemporal dementia cases are neuropathologically defined by tau-negative, TAR DNA-binding protein-43, and ubiquitin-positive inclusions in the brain and are associated with mutations in the progranulin gene (GRN). Deep sequencing of families exhibiting late-onset dementia revealed several novel variants in GRN. Because of the small size of these families and limited availability of samples, it was not possible to determine whether the variants segregated with the disease. Furthermore, none of these families had autopsy confirmation of diagnosis. We sought to determine if these novel GRN variants alter progranulin (PGRN) protein stability, PGRN secretion, and PGRN cleavage in cultured cells. All the novel GRN variants behave like PGRN wild-type protein, suggesting that these variants represent rare polymorphisms. However, it remains possible that these variants affect other aspects of PGRN function or represent risk factors for dementia when combined with other modifying genes.

Original languageEnglish
Pages (from-to)2538-2540
Number of pages3
JournalNeurobiology of Aging
Volume34
Issue number11
DOIs
StatePublished - Nov 1 2013

Keywords

  • Frontotemporal dementia
  • Granulin
  • Late-onset Alzheimer's disease
  • Progranulin

Fingerprint Dive into the research topics of 'Novel progranulin variants do not disrupt progranulin secretion and cleavage'. Together they form a unique fingerprint.

  • Cite this